4157.TWO

TaiGen Biopharmaceuticals Holdings Limited [4157.TWO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

4157.TWO Stock Summary

Top 10 Correlated ETFs

4157.TWO


Top 10 Correlated Stocks

4157.TWO


In the News

4157.TWO Financial details

Company Rating
Buy
Market Cap
10.7B
Income
136.88M
Revenue
123.13M
Book val./share
1.56
Cash/share
1.45
Dividend
-
Dividend %
-
Employees
52
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-80.46
Forward P/E
-
PEG
5.11
P/S
91.18
P/B
14.23
P/C
10.69
P/FCF
-62.66
Quick Ratio
16.76
Current Ratio
17.5
Debt / Equity
0.07
LT Debt / Equity
0.05
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-157.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
43.39%
Revenue Q/Q
-7.72%
EPS Q/Q
-2700%
-
-
-
-
SMA20
-0.92%
SMA50
-0.53%
SMA100
3.29%
Inst Own
-
Inst Trans
-
ROA
-16%
ROE
-17%
ROC
-0.15%
Gross Margin
91%
Oper. Margin
-123%
Profit Margin
-135%
Payout
-
Shs Outstand
717.84M
Shs Float
424.56M
-
-
-
-
Target Price
-
52W Range
13.85-18.75
52W High
-13.89%
52W Low
+19.23%
RSI
62.7
Rel Volume
1.51
Avg Volume
1.2M
Volume
1.82M
Perf Week
8.01%
Perf Month
2.65%
Perf Quarter
6.53%
Perf Half Y
7.27%
-
-
-
-
Beta
0.779
-
-
Volatility
0.29%, 0.38%
Prev Close
0.32%
Price
15.5
Change
0%

4157.TWO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.030.031.810.050.17
Net income per share
-0.41-0.561.08-0.330.19
Operating cash flow per share
-0.48-0.340.88-0.030.03
Free cash flow per share
-0.48-0.350.86-0.040.02
Cash per share
0.910.461.291.251.45
Book value per share
1.140.621.751.351.56
Tangible book value per share
1.090.571.721.341.56
Share holders equity per share
1.140.621.751.351.56
Interest debt per share
0.090.020.070.050.11
Market cap
13.19B16.38B11.04B11.51B10.79B
Enterprise value
13.12B16.34B10.73B11.3B10.49B
P/E ratio
-44.61-40.4614.23-48.5178.91
Price to sales ratio
649.27699.338.53317.5687.62
POCF ratio
-38.51-67.6617.55-540.94520.19
PFCF ratio
-37.95-65.3917.89-400.42808.37
P/B Ratio
16.1837.048.8111.869.64
PTB ratio
16.1837.048.8111.869.64
EV to sales
645.82697.478.29311.9285.19
Enterprise value over EBITDA
-51.91-43.8711.85-59.92-71.31
EV to operating cash flow
-38.3-67.4817.05-531.32505.73
EV to free cash flow
-37.74-65.2117.38-393.3785.89
Earnings yield
-0.02-0.020.07-0.020.01
Free cash flow yield
-0.03-0.020.0600
Debt to equity
0.080.040.040.040.07
Debt to assets
0.070.030.040.040.06
Net debt to EBITDA
0.280.12-0.341.092.04
Current ratio
7.884.1313.7118.523.19
Interest coverage
-278.67-671.853.59K-254.27-153.65
Income quality
1.180.60.720.090.15
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.263.30.0820.8
Research and developement to revenue
11.0110.650.226.561.52
Intangibles to total assets
0.040.050.010.010.01
Capex to operating cash flow
0.010.03-0.020.35-0.36
Capex to revenue
-0.25-0.36-0.01-0.21-0.06
Capex to depreciation
-0.15-0.27-0.41-0.26-0.27
Stock based compensation to revenue
00.620.03-0.140.2
Graham number
3.252.86.533.172.59
ROIC
-0.32-0.840.57-0.21-0.13
Return on tangible assets
-0.32-0.770.57-0.230.11
Graham Net
0.770.351.41.191.35
Working capital
614.51M296.69M1.14B897.92M1.06B
Tangible asset value
781.25M411.82M1.23B959.02M1.11B
Net current asset value
572.9M277.33M1.09B872.26M999.44M
Invested capital
0.080.040.040.040.07
Average receivables
17.63M35.6M158.42M153.84M30.33M
Average payables
-88K-22.29M-22.29M-164K-76K
Average inventory
3.76M11.09M16.26M16.61M24.75M
Days sales outstanding
633.51560.2579.2269.93100.39
Days payables outstanding
-8.45-4.02K-5.05-14.850
Days of inventory on hand
361.161.33K512.951.5K319.2
Receivables turnover
0.580.654.611.353.64
Payables turnover
-43.2-0.09-72.27-24.580
Inventory turnover
1.010.280.710.241.14
ROE
-0.36-0.920.62-0.240.12
Capex per share
-0.01-0.01-0.02-0.01-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.010.010.140.010.01
Net income per share
-0.16-0.070.01-0.010.26
Operating cash flow per share
-0.12-0.040.02-0.070.12
Free cash flow per share
-0.13-0.040.01-0.070.12
Cash per share
1.251.21.210.961.45
Book value per share
1.351.281.331.061.56
Tangible book value per share
1.341.261.311.061.56
Share holders equity per share
1.351.281.331.061.56
Interest debt per share
0.050.040.120.090.1
Market cap
11.51B10.75B12.8B12.45B10.8B
Enterprise value
11.3B10.54B12.74B12.44B10.5B
P/E ratio
-25.62-53.51319.83-363.7514.55
Price to sales ratio
2.43K1.87K128.641.34K1.26K
POCF ratio
-129-390.611.15K-206.05125.75
PFCF ratio
-126.88-367.491.42K-198.8127.73
P/B Ratio
11.8611.7313.4413.679.66
PTB ratio
11.8611.7313.4413.679.66
EV to sales
2.39K1.83K128.121.34K1.22K
Enterprise value over EBITDA
-113.67-243.39496.18-7.27K-133.24
EV to operating cash flow
-126.7-382.711.15K-205.87122.26
EV to free cash flow
-124.62-360.061.42K-198.63124.18
Earnings yield
-0.010000.02
Free cash flow yield
-0.0100-0.010.01
Debt to equity
0.040.030.090.090.07
Debt to assets
0.040.030.080.080.06
Net debt to EBITDA
2.065.02-2.026.33.81
Current ratio
18.513.6319.2317.523.19
Interest coverage
-591.76-316.84132.04-19.37-207.97
Income quality
0.790.550.617.060.46
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.444.080.222.323.77
Research and developement to revenue
15.475.810.465.226.92
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
0.020.06-0.190.04-0.02
Capex to revenue
-0.31-0.3-0.02-0.24-0.15
Capex to depreciation
-0.21-0.24-0.29-0.33-0.21
Stock based compensation to revenue
0.130.370.050.811.15
Graham number
2.181.420.650.493.01
ROIC
-0.1-0.050.01-0.01-0.07
Return on tangible assets
-0.11-0.050.01-0.010.15
Graham Net
1.191.131.10.881.35
Working capital
897.92M845.37M880.7M850.58M1.06B
Tangible asset value
959.02M905.23M941.13M897.82M1.11B
Net current asset value
872.26M828.33M809.5M783.49M999.44M
Invested capital
0.040.030.090.090.07
Average receivables
25.16M28.62M36.97M43.53M38.71M
Average payables
-152K-11.23M-11.23M-152K-76K
Average inventory
16.17M15.56M15.84M24.13M33.25M
Days sales outstanding
510.34475.5239.36421.07354.74
Days payables outstanding
-8.38-778.19-4.17-3.850
Days of inventory on hand
846.56550.15436.74819.81362.91
Receivables turnover
0.180.192.290.210.25
Payables turnover
-10.74-0.12-21.57-23.370
Inventory turnover
0.110.160.210.110.25
ROE
-0.12-0.050.01-0.010.17
Capex per share
00000

4157.TWO Frequently Asked Questions

What is TaiGen Biopharmaceuticals Holdings Limited stock symbol ?

TaiGen Biopharmaceuticals Holdings Limited is a TW stock and trading under the symbol 4157.TWO

What is TaiGen Biopharmaceuticals Holdings Limited stock quote today ?

TaiGen Biopharmaceuticals Holdings Limited stock price is $15.5 today.

Is TaiGen Biopharmaceuticals Holdings Limited stock public?

Yes, TaiGen Biopharmaceuticals Holdings Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap